4.35
-0.01(-0.23%)
Currency In USD
| Previous Close | 4.36 |
| Open | 4.3 |
| Day High | 4.37 |
| Day Low | 4.28 |
| 52-Week High | 10.37 |
| 52-Week Low | 4 |
| Volume | 85,539 |
| Average Volume | 279,985 |
| Market Cap | 232.79M |
| PE | -11.15 |
| EPS | -0.39 |
| Moving Average 50 Days | 4.64 |
| Moving Average 200 Days | 6.33 |
| Change | -0.01 |
If you invested $1000 in Alpha Teknova, Inc. (TKNO) since IPO date, it would be worth $174 as of September 08, 2025 at a share price of $4.35. Whereas If you bought $1000 worth of Alpha Teknova, Inc. (TKNO) shares 3 years ago, it would be worth $997.71 as of September 08, 2025 at a share price of $4.35.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Teknova to Report Second Quarter 2025 Financial Results on August 7, 2025
GlobeNewswire Inc.
Jul 24, 2025 8:05 PM GMT
HOLLISTER, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnosti
Teknova to Report First Quarter 2025 Financial Results on May 8, 2025
GlobeNewswire Inc.
Apr 24, 2025 11:51 PM GMT
HOLLISTER, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnost
Teknova and Pluristyx Launch Proprietary PluriFreeze™ Cryopreservation System to Accelerate the Development of Cell Therapies
GlobeNewswire Inc.
Mar 19, 2025 12:00 PM GMT
Innovative product line is purpose-built to streamline the manufacture of allogeneic cell therapies. Available exclusively from Teknova starting today.HOLLISTER, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TK